Ascletis Pharma Inc.
ASCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,749,378 | $1,282,237 | $4,123,604 | $34,861 |
| - Cash | $865,730 | $330,117 | $2,470,834 | $2,495,496 |
| + Debt | $7,633 | $8,416 | $4,237 | $2,750 |
| Enterprise Value | $891,281 | $960,536 | $1,657,007 | -$2,457,885 |
| Revenue | $1,283 | $56,596 | $54,090 | $76,876 |
| % Growth | -97.7% | 4.6% | -29.6% | – |
| Gross Profit | $735 | $25,990 | -$24,692 | $39,173 |
| % Margin | 57.3% | 45.9% | -45.6% | 51% |
| EBITDA | -$390,450 | -$126,091 | -$284,495 | -$169,347 |
| % Margin | -30,432.6% | -222.8% | -526% | -220.3% |
| Net Income | -$300,936 | -$144,715 | -$314,843 | -$199,017 |
| % Margin | -23,455.7% | -255.7% | -582.1% | -258.9% |
| EPS Diluted | -0.3 | -0.13 | -0.29 | -0.18 |
| % Growth | -130.8% | 55.2% | -61.1% | – |
| Operating Cash Flow | -$341,579 | -$144,162 | -$142,453 | -$146,930 |
| Capital Expenditures | -$2,148 | -$19,158 | -$14,401 | -$7,198 |
| Free Cash Flow | -$343,727 | -$163,320 | -$156,854 | -$154,128 |